The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

"Overall, the rise in early-onset cancer appears to be less an epidemic of disease and more an epidemic of diagnosis," Welch ...

At World Sleep 2025, a discussion group examined the emerging role of GLP-1 receptor agonists in obstructive sleep apnea (OSA ...

Welcome to The Nurses' Station, a new discussion board for nurses brought to you by MedPage Today.

On top of performing implantable cardioverter-defibrillator (ICD) functions, the integrated device also delivered appropriate ...

Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...

The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...

For all adults, excessive alcohol use is a leading preventable cause of death in the U.S. with over 178,000 deaths annually.